1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629289411117056 |
|---|---|
| author | Michael Bailey Andrew White Francesca Sparano Alessandra Cesano Corrado Caracò Ester Simeone Lucia Festino Alfredo Budillon Sarah Warren Domenico Mallardo Sarah Church Vito Vanella Ernesta Cavalcanti Paolo Ascierto Claudia Trojaniello Maria Grazia Vitale Margaret Ottaviano Paolo Chiodini Marilena Tuffanelli Mario Fordellone Bianca Arianna Facchini |
| author_facet | Michael Bailey Andrew White Francesca Sparano Alessandra Cesano Corrado Caracò Ester Simeone Lucia Festino Alfredo Budillon Sarah Warren Domenico Mallardo Sarah Church Vito Vanella Ernesta Cavalcanti Paolo Ascierto Claudia Trojaniello Maria Grazia Vitale Margaret Ottaviano Paolo Chiodini Marilena Tuffanelli Mario Fordellone Bianca Arianna Facchini |
| author_sort | Michael Bailey |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:51:08Z |
| format | Article |
| id | doaj.art-88c28a6e9f0a4bd8bd85c25a054338ec |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:51:08Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-88c28a6e9f0a4bd8bd85c25a054338ec2023-11-13T18:10:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12471247 Gene signature predict autoimmune toxicity in patients with metastatic melanomaMichael Bailey0Andrew White1Francesca Sparano2Alessandra Cesano3Corrado Caracò4Ester Simeone5Lucia Festino6Alfredo Budillon7Sarah Warren8Domenico Mallardo9Sarah Church10Vito Vanella11Ernesta Cavalcanti12Paolo Ascierto13Claudia Trojaniello14Maria Grazia Vitale15Margaret Ottaviano16Paolo Chiodini17Marilena Tuffanelli18Mario Fordellone19Bianca Arianna Facchini203 Department of Epidemiology and Preventive Medicine (DEPM), Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia6 Discipline of Ophthalmology, The University of Sydney, Sydney, New South Wales, AustraliaMedical Oncology, Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, ItalyESSA Pharma Inc, South San Francisco, California, USAAff1 grid.417893.00000 0001 0807 2568Istituto Nazionale TumoriFondazione G Pascale Naples ItalyIstituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, ItalyIstituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, ItalyAff1 grid.417893.00000000108072568IRCCS National Cancer Institute G. Pascale Napoli ItalyNanoString Technologies Inc, Seattle, Washington, USAIstituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, ItalyNanoString Technologies, Seattle, WA, USAAff1 0000 0001 0807 2568grid.417893.0Unit of Melanoma, Cancer Immunotherapy and Development TherapeuticsIstituto Nazionale Tumori IRCCS Fondazione “G. Pascale” Via Mariano Semmola 80131 Naples ItalyAff4 0000 0001 0807 2568grid.417893.0Department of Diagnostic Pathology and LaboratoryIstituto Nazionale Tumori- IRCCS –Fondazione G. Pascale Napoli Italy6Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, ItalyDepartment of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, ItalyDepartment of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, ItalyOncology Unit, Ospedale del Mare, Napoli, Campania, ItalyMedical Statistics Unit, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy1Istituto Nazionale Tumori IRCCS Pascale, Naples, Italy2Universitiy of Campania ‘Luigi Vanvitelli’, 81100 Naples, Italy., Naples, Italy1Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy |
| spellingShingle | Michael Bailey Andrew White Francesca Sparano Alessandra Cesano Corrado Caracò Ester Simeone Lucia Festino Alfredo Budillon Sarah Warren Domenico Mallardo Sarah Church Vito Vanella Ernesta Cavalcanti Paolo Ascierto Claudia Trojaniello Maria Grazia Vitale Margaret Ottaviano Paolo Chiodini Marilena Tuffanelli Mario Fordellone Bianca Arianna Facchini 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma Journal for ImmunoTherapy of Cancer |
| title | 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| title_full | 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| title_fullStr | 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| title_full_unstemmed | 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| title_short | 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| title_sort | 1247 gene signature predict autoimmune toxicity in patients with metastatic melanoma |
| work_keys_str_mv | AT michaelbailey 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT andrewwhite 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT francescasparano 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT alessandracesano 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT corradocaraco 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT estersimeone 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT luciafestino 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT alfredobudillon 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT sarahwarren 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT domenicomallardo 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT sarahchurch 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT vitovanella 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT ernestacavalcanti 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT paoloascierto 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT claudiatrojaniello 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT mariagraziavitale 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT margaretottaviano 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT paolochiodini 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT marilenatuffanelli 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT mariofordellone 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma AT biancaariannafacchini 1247genesignaturepredictautoimmunetoxicityinpatientswithmetastaticmelanoma |